Literature DB >> 22725839

Enantioselective synthesis of a dual orexin receptor antagonist.

Ian K Mangion1, Benjamin D Sherry, Jingjun Yin, Fred J Fleitz.   

Abstract

A concise, enantioselective synthesis of the potent dual orexin inhibitor suvorexant (1) is reported. Key features of the synthesis include a mild copper-catalyzed amination, a highly chemoselective conjugate addition, and a tandem enantioselective transamination/seven-membered ring annulation. The synthesis requires inexpensive starting materials and only four linear steps for completion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22725839     DOI: 10.1021/ol3014123

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Development of an Intermittent-Flow Enantioselective Aza-Henry Reaction Using an Arylnitromethane and Homogeneous Brønsted Acid-Base Catalyst with Recycle.

Authors:  Sergey V Tsukanov; Martin D Johnson; Scott A May; Morgan Rosemeyer; Michael A Watkins; Stanley P Kolis; Matthew H Yates; Jeffrey N Johnston
Journal:  Org Process Res Dev       Date:  2016-02-01       Impact factor: 3.317

2.  Identification of ortho-Substituted Benzoic Acid/Ester Derivatives via the Gas-Phase Neighboring Group Participation Effect in (+)-ESI High Resolution Mass Spectrometry.

Authors:  William D Blincoe; Agustina Rodriguez-Granillo; Josep Saurí; Nicholas A Pierson; Leo A Joyce; Ian Mangion; Huaming Sheng
Journal:  J Am Soc Mass Spectrom       Date:  2018-02-27       Impact factor: 3.109

3.  Heterogeneous Co-catalyzed direct 2-alkylation of azoles with ethers.

Authors:  Ke Yang; Dashan Li; Lei Zhang; Qun Chen; Tiandi Tang
Journal:  RSC Adv       Date:  2018-04-12       Impact factor: 3.361

4.  The Industrial Age of Biocatalytic Transamination.

Authors:  Michael Fuchs; Judith E Farnberger; Wolfgang Kroutil
Journal:  European J Org Chem       Date:  2015-09-23

Review 5.  Transaminases for industrial biocatalysis: novel enzyme discovery.

Authors:  Stephen A Kelly; Stefan Mix; Thomas S Moody; Brendan F Gilmore
Journal:  Appl Microbiol Biotechnol       Date:  2020-04-16       Impact factor: 4.813

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.